newsfilter
← Latest News
GlobeNewswire·

Instil Bio Announces Voluntary Pause of Enrollment in Ongoing Clinical Trials Related to Manufacturing

Voluntarily paused enrollment in ITIL-168 and ITIL-306 trials pending outcome of manufacturing analysis and implementation of corrective actionsNo regulatory agency, including the FDA, has notified the Company of a